New Delhi February 24, 2014:- The government on Thursday cleared a Rs 6,400 crore foreign direct investment proposal of global healthcare company GlaxoSmithKline to acquire additional 24.33 per cent stake in its India arm.
Home Research & Development (R&D) US FDA Approval GlaxoSmithKline’s Rs 6,400 cr FDI proposal cleared
